Рекомендации по коморбидности
Оганов Р.Г., Симаненков В.И., Бакулин И.Г. и др. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения // Кардиоваскулярная терапия и профилактика. 2019. Т. 18, № 1. С. 5-66.
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace.
2021. Apr. Vol. 25. P. euab065.
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases // Arthritis & Rheumatology. 2020. Vol. 72, N 4. P. 461-488.
2020 Expert Consensus Decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes // J. Am. Coll. Cardiol. 2020. Vol. 76, N 9.
P. 1117-1145.
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD // Eur. Heart J. 2020. Vol. 2. P. 255-323.
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy // European Heart Journal. 2018. Vol. 39. P. 3165-241.
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions // EP Europace. 2019. Vol. 21.
P. 192-193.
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum. Thyroid.
March 2017. Vol. 27, N 3. P. 315-389.
AHA/ACC/HHS Strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions // Circulation. 2014.
Vol. 130, N 18. P. 1662-1667.